Impact of Angiotensin I-converting Enzyme Inhibitors and Angiotensin II Type-1 Receptor Blockers on Survival of Patients with NSCLC

It has been shown that angiotensin I-converting enzyme inhibitors (ACEIs) and angiotensin II type-1 receptor blockers (ARBs) can decrease tumor growth and tumor-associated angiogenesis and inhibit metastasis. Epidermal growth factor receptor (EGFR) mutations are found in approximately 30% of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Lili, Chen, Wei, Zhou, Ling, Wan, Huanying, Gao, Beili, Feng, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756359/
https://www.ncbi.nlm.nih.gov/pubmed/26883083
http://dx.doi.org/10.1038/srep21359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756359/
https://www.ncbi.nlm.nih.gov/pubmed/26883083
http://dx.doi.org/10.1038/srep21359

Ejemplares similares